Scinai Immunotherapeutics (SCNI) Total Debt Growth (1y) (2019 - 2025)
Scinai Immunotherapeutics (SCNI) Total Debt Growth (1y) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 5.94% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Scinai Immunotherapeutics | 3.02 Bn | 988.23 Mn | - | 19.30% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 19.30% |
| Jun 30, 2025 | -96.09% |
| Dec 31, 2024 | -96.54% |
| Sep 30, 2024 | -96.61% |
| Jun 30, 2024 | -14.79% |
| Mar 31, 2024 | -8.94% |
| Dec 31, 2023 | -3.42% |
| Sep 30, 2023 | 12.06% |
| Jun 30, 2023 | 44.21% |
| Mar 31, 2023 | -1.94% |
| Dec 31, 2022 | -25.69% |
| Sep 30, 2022 | -22.29% |
| Jun 30, 2022 | -99.98% |
| Mar 31, 2022 | -99.97% |
| Dec 31, 2021 | -99.96% |
| Sep 30, 2021 | 14.51% |
| Jun 30, 2021 | -45.29% |
| Mar 31, 2021 | -45.09% |
| Dec 31, 2020 | 185,596.34% |
| Sep 30, 2020 | -38.82% |